GNPX Genprex Inc.

1.68
-0.04  -2%
Previous Close 1.72
Open 1.69
Price To Book 3.65
Market Cap 26209285
Shares 15,600,765
Volume 23,083
Short Ratio
Av. Daily Volume 57,540

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 interim data released January 2017. Patient enrollment to resume - noted August 2, 2018.
Oncoprex With Tarceva
Non-small cell lung cancer (NSCLC)

Latest News

  1. Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
  2. Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
  3. Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
  4. Genprex Retains Addison Whitney for Drug Nomenclature Branding
  5. Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for Cancer
  6. Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
  7. Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies
  8. Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
  9. Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
  10. Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
  11. Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment
  12. Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
  13. Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
  14. Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy
  15. Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
  16. NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene Therapy
  17. NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene Therapy
  18. Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
  19. NetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market Profitability
  20. 5 Biotech Stocks to Keep an Eye on in 2019